Skip to content

RODILO: what changed

BE 0801.891.476NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparationsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€50,210
2024 · -€204,573+€154,364
Equity
-€89,783
2024 · -€67,573-€22,210
Cash
€21,219
2024 · €16,281+€4,938
Balance sheet total
€204,587
2024 · €185,547+€19,040

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets +€12,871

    up €12,871 (+7.8%), from €165,771 to €178,643

  • Cash +€4,938

    up €4,938 (+30.3%), from €16,281 to €21,219

    mainly Debts after one year (+€56,055) and Contributions, distributions and other (+€28,000)

Equity and liabilities
  • Debts after one year +€56,055

    up €56,055 (+30.0%), from €186,680 to €242,735

  • Profit (loss) carried forward -€50,210

    down €50,210 (-24.5%), from -€204,573 to -€254,783

  • Contributions +€28,000

    up €28,000 (+20.4%), from €137,000 to €165,000

  • Short-term financial debts -€11,010

    down €11,010 (-21.3%), from €51,570 to €40,560

    of which Other loans: -€11,118

  • Accrued charges and deferred income -€10,430

    down €10,430 (-70.1%), from €14,871 to €4,440

Income statement
  • Depreciation -€81,636

    down €81,636 (-89.3%), from €91,425 to €9,789

  • Gross operating margin +€48,839

    up €48,839 (+95.6%), from -€51,093 to -€2,254

  • Other operating charges -€23,023

    down €23,023 (-48.9%), from €47,055 to €24,032

  • Financial charges -€866

    down €866 (-5.8%), from €15,000 to €14,135

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€204,573
Gross operating margin +€48,839
Depreciation +€81,636
Other operating charges +€23,023
Financial income -€0
Financial charges +€866
Result 2025 -€50,210
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€45,567
Investment -€22,539
Financing +€73,045
Cash 2024 €16,281
Net result for the year -€50,210
Depreciation +€9,789
Receivables within one year -€1,362
Deferred charges and accrued income +€11
Trade debts +€6,635
Accrued charges and deferred income -€10,430
Investment in fixed assets (net) -€22,539
Debts after one year +€56,055
Short-term financial debts -€11,010
Contributions, distributions and other +€28,000
Cash 2025 €21,219
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €185,547 €204,587 +€19,040 +10.3%
Formation expenses 20 €409 €288 -€121 -29.6%
Fixed assets 21/28 €165,771 €178,643 +€12,871 +7.8%
Intangible fixed assets 21 €165,771 €178,643 +€12,871 +7.8%
Current assets 29/58 €19,367 €25,657 +€6,290 +32.5%
Amounts receivable within one year 40/41 €3,038 €4,399 +€1,362 +44.8%
Trade receivables 40 €2,400 €2,811 +€411 +17.1%
Other amounts receivable 41 €638 €1,588 +€951 +149%
Cash at bank and in hand 54/58 €16,281 €21,219 +€4,938 +30.3%
Deferred charges and accrued income 490/1 €49 €38 -€11 -21.6%
Total equity and liabilities 10/49 €185,547 €204,587 +€19,040 +10.3%
Equity 10/15 -€67,573 -€89,783 -€22,210 -32.9%
Contributions 10/11 €137,000 €165,000 +€28,000 +20.4%
Profit (loss) carried forward 14 -€204,573 -€254,783 -€50,210 -24.5%
Amounts payable 17/49 €253,121 €294,370 +€41,249 +16.3%
Amounts payable after more than one year 17 €186,680 €242,735 +€56,055 +30.0%
Other amounts payable 178/9 €186,680 €242,735 +€56,055 +30.0%
Amounts payable within one year 42/48 €51,570 €47,195 -€4,375 -8.5%
Financial debts 43 €51,570 €40,560 -€11,010 -21.3%
Credit institutions 430/8 - €108 +€108
Other loans 439 €51,570 €40,452 -€11,118 -21.6%
Trade debts 44 - €6,635 +€6,635
Suppliers 440/4 - €6,635 +€6,635
Accrued charges and deferred income 492/3 €14,871 €4,440 -€10,430 -70.1%
Non-recurring operating income 76A - €22,539 +€22,539
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €91,425 €9,789 -€81,636 -89.3%
Other operating charges 640/8 €47,055 €24,032 -€23,023 -48.9%
Gross operating margin 9900 -€51,093 -€2,254 +€48,839 +95.6%
Operating profit (loss) 9901 -€189,573 -€36,075 +€153,498 +81.0%
Financial income 75/76B €0 €0 -€0 -100%
Recurring financial income 75 €0 €0 -€0 -100%
Financial charges 65/66B €15,000 €14,135 -€866 -5.8%
Recurring financial charges 65 €15,000 €14,135 -€866 -5.8%
Profit (loss) for the period before taxes 9903 -€204,573 -€50,210 +€154,364 +75.5%
Profit (loss) for the period 9904 -€204,573 -€50,210 +€154,364 +75.5%
Profit (loss) for the period to be appropriated 9905 -€204,573 -€50,210 +€154,364 +75.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€268,713

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€89,783
Formation expenses (20)
-€288
Intangible fixed assets (21)
-€178,643
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€268,713

Capitalised earnings

net result for the year (9904)
2025
-€50,210
excluding non-recurring income and charges
-€72,749
2024
-€204,573
Average result, excluding non-recurring income and charges
-€138,661
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.